IL46696A - Substituted n-(2-pyrrolidinylalkyl)benzamides, their preparation and pharmaceutical compositions containing them - Google Patents

Substituted n-(2-pyrrolidinylalkyl)benzamides, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL46696A
IL46696A IL46696A IL4669675A IL46696A IL 46696 A IL46696 A IL 46696A IL 46696 A IL46696 A IL 46696A IL 4669675 A IL4669675 A IL 4669675A IL 46696 A IL46696 A IL 46696A
Authority
IL
Israel
Prior art keywords
pyrrolidinylalkyl
benzamides
substituted
preparation
pharmaceutical compositions
Prior art date
Application number
IL46696A
Other languages
English (en)
Other versions
IL46696A0 (en
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7407535A external-priority patent/FR2262966A1/fr
Priority claimed from FR7503800A external-priority patent/FR2299863B1/fr
Application filed by Ile De France filed Critical Ile De France
Publication of IL46696A0 publication Critical patent/IL46696A0/xx
Publication of IL46696A publication Critical patent/IL46696A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL46696A 1974-03-05 1975-02-24 Substituted n-(2-pyrrolidinylalkyl)benzamides, their preparation and pharmaceutical compositions containing them IL46696A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7407535A FR2262966A1 (en) 1974-03-05 1974-03-05 N-(2-azacycloalkyl-alkyl)-benzamide derivs. - with antiemetic, antiulcer and CNS activity
FR7503800A FR2299863B1 (fr) 1975-02-07 1975-02-07 Nouveaux N-(Z-pyrrolidiny alkyl) benzamides substitués, leurs dérivés et leur procédé de préparation

Publications (2)

Publication Number Publication Date
IL46696A0 IL46696A0 (en) 1975-04-25
IL46696A true IL46696A (en) 1978-07-31

Family

ID=26218210

Family Applications (1)

Application Number Title Priority Date Filing Date
IL46696A IL46696A (en) 1974-03-05 1975-02-24 Substituted n-(2-pyrrolidinylalkyl)benzamides, their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
JP (1) JPS6015616B2 (de)
AR (1) AR206621A1 (de)
AT (1) AT358570B (de)
BG (1) BG24666A3 (de)
CA (1) CA1047504A (de)
CH (1) CH605794A5 (de)
CS (1) CS189692B2 (de)
DD (1) DD119420A5 (de)
DE (1) DE2507989A1 (de)
DK (1) DK145377C (de)
EG (1) EG12577A (de)
ES (1) ES435274A1 (de)
FI (1) FI750620A (de)
GB (1) GB1466822A (de)
HK (1) HK14078A (de)
HU (1) HU170637B (de)
IE (1) IE40818B1 (de)
IL (1) IL46696A (de)
LU (1) LU71949A1 (de)
NL (1) NL7502608A (de)
NO (1) NO750713L (de)
OA (1) OA04966A (de)
PH (1) PH14197A (de)
PL (1) PL97091B1 (de)
RO (2) RO72844A (de)
SE (1) SE411754B (de)
SU (1) SU609464A3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
SE8503054D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Catecholcarboxamides
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
EP0314483A1 (de) * 1987-10-29 1989-05-03 Erbamont, Inc. Herstellung von Benzamiden
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3078497A (en) * 1960-12-29 1963-02-26 Leeds And Mieallef Dispensing containers

Also Published As

Publication number Publication date
JPS6015616B2 (ja) 1985-04-20
CS189692B2 (en) 1979-04-30
IE40818L (en) 1975-09-05
CA1047504A (en) 1979-01-30
JPS50123668A (de) 1975-09-29
IE40818B1 (en) 1979-08-29
RO70647A (ro) 1980-04-15
FI750620A (de) 1975-09-06
DK145377C (da) 1983-04-11
AT358570B (de) 1980-09-25
CH605794A5 (de) 1978-10-13
PL97091B1 (pl) 1978-02-28
IL46696A0 (en) 1975-04-25
DE2507989A1 (de) 1975-09-11
SE411754B (sv) 1980-02-04
PH14197A (en) 1981-03-26
ATA160775A (de) 1980-02-15
BG24666A3 (en) 1978-04-12
SU609464A1 (de) 1978-05-30
SE7502342L (de) 1975-09-08
LU71949A1 (de) 1976-02-04
NO750713L (de) 1975-09-08
GB1466822A (en) 1977-03-09
DK86975A (de) 1975-11-03
SU609464A3 (ru) 1978-05-30
DK145377B (da) 1982-11-08
HU170637B (de) 1977-07-28
EG12577A (en) 1979-09-30
OA04966A (fr) 1980-10-31
NL7502608A (nl) 1975-09-09
ES435274A1 (es) 1976-12-16
HK14078A (en) 1978-03-23
DD119420A5 (de) 1976-04-20
AR206621A1 (es) 1976-08-06
RO72844A (ro) 1981-09-24
AU7874075A (en) 1976-09-09

Similar Documents

Publication Publication Date Title
IL49204A0 (en) N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them
IL48642A (en) 3-amino-indazolecarboxylic acid derivatives,ther preparation and pharmaceutical compositions containing them
IL46695A (en) Substituted n-(1-benzylpyrrolidinyl-2-alkyl)-benzamides, their preparation and pharmaceutical compositions containing them
IL47269A (en) Amido phenylguanidine derivatives, their preparation and pharmaceutical compositions containing them
IL46966A0 (en) 1,1-diaryl-1-oxadiazolyl-alkylamines,their preparation and pharmaceutical compositions containing them
IL47529A0 (en) New benzimidazolinone derivatives,their preparation and pharmaceutical compositions containing them
IL47170A0 (en) New phenylalkylamines,their preparation and pharmaceutical compositions containing them
IL48061A (en) 4a-phenyl-cis-decahydroisoquinoline derivatives, their preparation and pharmaceutical compositions containing them
IL46894A0 (en) New antibiotics,their preparation and pharmaceutical compositions containing them
IL47329A0 (en) New pyridobenzodiazepinones,their preparation and pharmaceutical compositions containing them
KE2900A (en) N-(1-benzylpiperid-4-yl)-benzamides, methods for their preparation and pharmaceutical compositions containing them
NZ178313A (en) Certain amines, and pharmaceutical compositions containingthem
IL48678A0 (en) N-(2-pyrrolidinylmethyl)-2-methoxybenzamide derivatives,their preparation and pharmaceutical compositions containing them
IL47149A0 (en) New amino acid derivatives,their preparation and pharmaceutical compositions containing them
IL47404A0 (en) Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them
IL47590A0 (en) Vincaminic acid amides,their preparation and pharmaceutical compositions containing them
IL47196A0 (en) New 7-substituted-8-aminomethyl-isoflavone derivatives,their preparation and pharmaceutical compositions containing them
IL46696A (en) Substituted n-(2-pyrrolidinylalkyl)benzamides, their preparation and pharmaceutical compositions containing them
IL47892A0 (en) Novel cinnamamide derivatives,their preparation and pharmaceutical compositions containing them
IL47195A0 (en) New 5-substituted phenyltetrazoles,their preparation and pharmaceutical compositions containing them
IL47270A0 (en) New peptides,their preparation and pharmaceutical compositions containing them
IL48526A0 (en) Diaryloxy-imidazolyl-o,n-acetals,their preparation and pharmaceutical compositions containing them
IL46409A (en) 7,8-dihalo-1,2,3,4-tetrahydro-isoquinolines their preparation and pharmaceutical compositions containing them
IL47522A0 (en) Ergopeptine derivatives,their preparation and pharmaceutical compositions containing them
IL47654A0 (en) New thieno-pyridine derivatives,their preparation and pharmaceutical compositions containing them